Related Experiment Video
Updated: May 29, 2025
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
18.6K
Enhanced glycemic control and cardiovascular risk reduction in type 2 diabetes patients using quantified tableware: A
Ching-Hsiang Leung1, Min-Su Tzeng2, Chia-Ying Tsai3
1Division of Endocrinology and Metabolism, Department of Internal Medicine, Mackay Memorial Hospital, Taipei, Taiwan.
Primary Care Diabetes
|February 6, 2025
Summary
Quantified tableware (QTW) significantly improved glycemic control in type 2 diabetes patients. This nutrition therapy aid enhanced HbA1c levels and helped patients achieve key health goals.
Area of Science:
- Endocrinology
- Nutrition Science
- Public Health
Background:
- Diabetes management requires effective strategies for blood glucose, blood pressure, and lipid control.
- Cardiovascular disease and stroke are significant risks for diabetic patients.
- Tableware offers a practical approach to portion control and accurate food measurement.
Purpose of the Study:
- To investigate the impact of quantified tableware (QTW) on glycemic control in type 2 diabetes mellitus (T2DM) patients.
- To assess QTW's effect on achieving ABC goals (HbA1c, blood pressure, LDL).
Main Methods:
- Prospective, randomized study with 94 T2DM participants.
- Intervention group used QTW for precise food measurement and proportioning.
- Control group received standard dietary counseling.
Main Results:
- The QTW group showed a significant reduction in HbA1c compared to the control group (-0.7% vs -0.2%, p=0.037).
- More patients in the QTW group achieved HbA1c <7% (32.4% vs 11.6%, p=0.026).
- The intervention group demonstrated improved achievement of LDL goals and combined ABC goals.
Conclusions:
- Quantified tableware is an effective tool for enhancing glycemic control in T2DM patients.
- QTW use can improve blood pressure and lipid profiles, contributing to better overall health outcomes.
- Further research is warranted to explore the wider applications of QTW in diabetes management.
Related Concept Videos
01:15Diabetes: Management and Pharmacotherapy
232
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
232
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
114
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
114
01:19Oral Hypoglycemic Agents: α-Glucosidase Inhibitors
146
α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...
Acarbose and miglitol are...
146
01:23Dipeptidyl Peptidase 4 Inhibitors
164
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
164
01:36Carbohydrate Metabolism
10.7K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.7K